BGI-Shenzhen Agrees to Buy Complete Genomics

BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics Inc. for about $117.6 million to expand in the U.S. market for medical and research DNA testing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.